103 related articles for article (PubMed ID: 20702235)
1. The potential usefulness of a differentiating teratocarcinoma cell line in in vitro toxicity testing.
Hulme LM; Atkinson KA; Clothier RH; Balls M
Toxicol In Vitro; 1990; 4(4-5):589-92. PubMed ID: 20702235
[TBL] [Abstract][Full Text] [Related]
2. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
Webster WS; Brown-Woodman PD; Ritchie HE
Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
[TBL] [Abstract][Full Text] [Related]
3. The stem-cell test-A novel in vitro assay for teratogenic potential.
Newall DR; Beedles KE
Toxicol In Vitro; 1994 Aug; 8(4):697-701. PubMed ID: 20692990
[TBL] [Abstract][Full Text] [Related]
4. [Noninduced single-stranded breaks in DNA in murine F9 teratocarcinoma cells].
Kisliakova TV; Kustova ME; Lianguzova MS; Malashcheva AB; Strunnikova MA; Suchkova IO; Pospelov VA; Patkin EL
Tsitologiia; 2000; 42(11):1060-8. PubMed ID: 11204650
[TBL] [Abstract][Full Text] [Related]
5. Autocrine downregulation of fibroblast growth factor receptors in F9 teratocarcinoma cells.
Moscatelli D
J Cell Physiol; 1994 Sep; 160(3):555-62. PubMed ID: 8077293
[TBL] [Abstract][Full Text] [Related]
6. The stem-cell test: an in vitro assay for teratogenic potential. Results of a blind trial with 25 compounds.
Newall DR; Beedles KE
Toxicol In Vitro; 1996 Apr; 10(2):229-40. PubMed ID: 20650201
[TBL] [Abstract][Full Text] [Related]
7. Regulation of platelet-derived growth factor A messenger RNA translation in differentiating F9 teratocarcinoma cells.
Wang C; Stiles CD
Cell Growth Differ; 1993 Oct; 4(10):871-7. PubMed ID: 8274456
[TBL] [Abstract][Full Text] [Related]
8. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
9. In vitro induction of differentiation by ginsenoides in F9 teratocarcinoma cells.
Lee YN; Lee HY; Chung HY; Kim SI; Lee SK; Park BC; Kim KW
Eur J Cancer; 1996 Jul; 32A(8):1420-8. PubMed ID: 8869109
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid induces parietal endoderm but not primitive endoderm and visceral endoderm differentiation in F9 teratocarcinoma stem cells with a targeted deletion of the Rex-1 (Zfp-42) gene.
Thompson JR; Gudas LJ
Mol Cell Endocrinol; 2002 Sep; 195(1-2):119-33. PubMed ID: 12354678
[TBL] [Abstract][Full Text] [Related]
11. A blockade in Wnt signaling is activated following the differentiation of F9 teratocarcinoma cells.
Shibamoto S; Winer J; Williams M; Polakis P
Exp Cell Res; 2004 Jan; 292(1):11-20. PubMed ID: 14720502
[TBL] [Abstract][Full Text] [Related]
12. [Apoptotic cell death of F9 mouse embryonal teratocarcinoma depends on cell population density].
Malashicheva AB; Kisliakova TV; Pospelov VA
Tsitologiia; 1998; 40(1):14-22. PubMed ID: 9541970
[TBL] [Abstract][Full Text] [Related]
13. Expression of syndecan-1 changes during the differentiation of visceral and parietal endoderm from murine F9 teratocarcinoma cells.
Jiang R; Kato M; Bernfield M; Grabel LB
Differentiation; 1995 Nov; 59(4):225-33. PubMed ID: 8575644
[TBL] [Abstract][Full Text] [Related]
14. Expression and localization of villin, fimbrin, and myosin I in differentiating mouse F9 teratocarcinoma cells.
Ezzell RM; Leung J; Collins K; Chafel MM; Cardozo TJ; Matsudaira PT
Dev Biol; 1992 Jun; 151(2):575-85. PubMed ID: 1601186
[TBL] [Abstract][Full Text] [Related]
15. [Antiproliferative and cytotoxic effects of different type cytostatics on mouse pluripotent stem and teratocarcinoma cells].
Gordeeva OF
Ontogenez; 2012; 43(4):268-77. PubMed ID: 23035583
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet irradiation, although it activates the transcription factor AP-1 in F9 teratocarcinoma stem cells, does not induce the full complement of differentiation-associated genes.
Auer HP; König H; Litfin M; Stein B; Rahmsdorf HJ
Exp Cell Res; 1994 Sep; 214(1):131-8. PubMed ID: 7521841
[TBL] [Abstract][Full Text] [Related]
17. A new differentiated cell line (Dif 5) derived by retinoic acid treatment of F9 teratocarcinoma cells capable of extracellular matrix production and growth in the absence of serum.
Nagarajan L; Jetten AM; Anderson WB
Exp Cell Res; 1983 Sep; 147(2):315-27. PubMed ID: 6193979
[TBL] [Abstract][Full Text] [Related]
18. Specific growth stimulation in the absence of specific cellular adhesion in lung colonization by retinoic-acid-treated F9 teratocarcinoma cells.
Rusciano D; Lorenzoni P; Burger MM
Int J Cancer; 1992 Sep; 52(3):471-7. PubMed ID: 1399123
[TBL] [Abstract][Full Text] [Related]
19. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).
Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H
Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of the cDNAs corresponding to mRNAs abundant in undifferentiated mouse embryonal teratocarcinoma stem cells, but not in differentiated mouse parietal endoderm cells.
Ikuma S; Kiyota M; Setoyama C; Shimada K
J Biochem; 1986 Nov; 100(5):1185-92. PubMed ID: 2434467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
